Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: A prospective evaluation of risk factors and outcome

Bone Marrow Transplantation

Volumn 34, Issue 12, 2004, Pages 1051-1055

  Gonzalez Vicent M ^a   Ramirez M ^a   Sevilla, J ^a   Perez A ^a   Fernandez S ^a   Madero, L ^a   Diaz M A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Autologous PBPC transplantation and children; Engraftment syndrome

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; BUSULFAN; CARBOPLATIN; CARMUSTINE; CD34 ANTIGEN; CLONAZEPAM; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ETOPOSIDE; HEPARIN; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; TOPOTECAN;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BRAIN DISEASE; CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; ENGRAFTMENT SYNDROME; FEBRILE NEUTROPENIA; FEMALE; FEVER; FOLLOW UP; GRAFT REJECTION; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; INFECTION COMPLICATION; KIDNEY FAILURE; LIVER DYSFUNCTION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; RISK ASSESSMENT; SEIZURE; SOLID TUMOR; SURVIVAL RATE; TREATMENT OUTCOME; VEIN OCCLUSION;

ADOLESCENT; ANTIGENS, CD34; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; EXANTHEMA; FEMALE; FEVER; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; PULMONARY EDEMA; RISK FACTORS; SYNDROME; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 11144252802     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704698     Document Type: Article

References (16)

1. Madero L, Vicent MG, Sevilla J et al. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002; 30: 355-358.
2. Edentield WJ, Moores LK, Goodwin G, Lee N. An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose. Bone Marrow Transplant 2000; 25: 405-409.
3. Ravoet C, Feremans W, Husson B et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant 1996; 18: 943-947.
4. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893-898.
5. Lee C-K, Gingrich RD, Hohl RJ, Ajram KA. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995; 16: 175-182.
6. González-Vicent M, Madero L, Sevilla J, Diaz MA. Clinical and economic evaluation of using granulocyte colony-stimulating factor after autologous peripheral blood progenitor cell transplantation in children. Haematologica 2002; 87: 105-106.
7. Sevilla J, González-Vicent M, Madero L et al. Granulocyte colony-stimulating factor alone at 12 mcg/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patients. Bone Marrow Transplant 2002; 30: 417-420.
8. Díaz MA, Alegre A, Villa M et al. Collection and transplantation of peripheral blood progenitor cells mobilized by G-CSF alone in children with malignancy. Br J Haematol 1996; 94: 148-154.
9. Capizzi SA, Kumar S, Huneke NE et al. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 1299-1303.
10. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-220.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
12. Akasheh M, Eastwood D, Vesole DH. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) vs granulocyte-macrophage colony-stimulating factor (GM-CSF). Bone Marrow Transplant 2003; 31: 113-116.
13. Moreb JS, Kubilis PS, Mullins DL et al. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients. Bone Marrow Transplant 1997; 19: 101-106.
14. Teder P, Vandivier RW, Jiang D et al. Resolution of lung inflammation by CD44. Science 2002; 296: 155-158.
15. Li MO, Sarkisian MR, Mehal WZ et al. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 2003; 302: 1560-1563.
16. Maiolino A, Biasoli I, Lima J et al. Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria. Bone Marrow Transplant 2003; 31: 393-397.